Regular Article
Estimation of a Chromium Inhalation Reference Concentration Using the Benchmark Dose Method: A Case Study

https://doi.org/10.1006/rtph.1994.1036Get rights and content

Abstract

The benchmark dose (BD) method has been proposed as an alternative to the NOAEL/UF method for setting reference levels. The BD is the 95% lower confidence limit on a dose corresponding to a 10% increase (or relative change) in an adverse effect. A case study exploring the suitability of the current Cr(III) and Cr(VI) inhalation toxicity data bases to the BD approach is presented. Because chromic acid mists, typical of many occupational Cr(VI) exposures, present a toxicological profile different from that of Cr(VI) particulates, representative of environmental exposures, Cr(VI) particulate data were evaluated separately from Cr(VI) acidic mist data. The current Cr(III) and Cr(VI) acidic mist data bases proved inadequate for BD analysis due to data and/or study quality limitations. Benchmark reference concentrations (RfCs) for particulate Cr(VI) ranging from 0.34 μg/m3 (for lactate dehydrogenase (LDH) in bronchoalveolar lavage fluid (BALF)) to 1.4 μg/m3 (for increased lung weights) are derived from data taken from U. Glaser et al. (Arch. Toxicol.57, 250-256, 1985) and U. Glaser et al. (Environmental Hygiene II, Springer-Verlag, Berlin/New York, 1990). A Cr(VI) particulate RfC of 0.34 μg/m3 based upon LDH in BALF as the critical effect is proposed. This value may be viewed as conservative since it represents the 95% lower confidence limit on the dose associated with a 10% increase in response for a sensitive endpoint and has appropriate dosimetric adjustments and uncertainty factors incorporated.

References (0)

Cited by (14)

  • Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches

    2021, Regulatory Toxicology and Pharmacology
    Citation Excerpt :

    Noncancer data amenable to modeling were not presented in Glaser et al. (1986); therefore, selected noncancer endpoints were modeled from subchronic rat inhalation studies (Glaser et al., 1985, 1990). Selection of endpoints was informed by Malsch et al. (1994), who modeled various endpoints well before the release of the US EPA's BMD software. Similar to the cancer modeling, air concentrations were extrapolated to HEC using information presented in Supplemental Table 6 and were used to model the various effects shown in Supplemental Table 7.

  • Different roles of ROS and Nrf2 in Cr(VI)-induced inflammatory responses in normal and Cr(VI)-transformed cells

    2016, Toxicology and Applied Pharmacology
    Citation Excerpt :

    Hexavalent chromium Cr(VI) is classified as a human carcinogen. Exposure to Cr(VI) occurs in multiple occupational environments due to its commercial usage in welding, chrome pigmenting, leather tanning, and ferrochrome industry (Fishbein, 1981; Malsch et al., 1994). Cr(VI) is also a component of industrial waste and atmospheric pollution.

  • Mathematical modelling and quantitative methods

    2002, Food and Chemical Toxicology
View all citing articles on Scopus
View full text